City

Chicago (1)

Duarte (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

City of Hope Medical Center (1)

University of Chicago (1)

Collaborator

National Cancer Institute (NCI) (1)

Verastem, Inc. (1)

Intervention

balstilimab (1)

biospecimen collection (1)

botensilimab (1)

cetuximab (1)

computed tomography (1)

pill diary (1)

regorafenib (1)

vs-6766 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

advanced colorectal adenocarcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting

Advanced Colorectal Adenocarcinoma
+5 more

Balstilimab
+4 more

Duarte, California

City of Hope Medical Center

Jan 3, 2023

Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)

Not yet recruiting

Colorectal Cancer
+4 more

VS-6766
+2 more

Chicago, Illinois

University of Chicago Medical Center

Jan 6, 2022